CNCRLoncar Cancer Immunotherapy ETF
CNCR Fund Description
CNCR tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs.
CNCR Factset Analytics Insight
CNCR takes an approach to niche coverage within the health care sector. It provides equal-weighted exposure to about 30 companies of various sizes that have approved immunotherapy cancer drugs on the US or European markets or that are engaged in human clinical trials of such drugs. The fund seeks a holistic exposure to the immunotherapy space, specifically including companies with varying drug mechanisms. Equal-weighting of the securities draws attention to smaller companies with room to grow. This fund provides a unique option for investors placing a highly specialized bet on this space.
CNCR MSCI ESG Analytics Insight
Loncar Cancer Immunotherapy ETF has an MSCI ESG Fund Rating of A based on a score of 6.68 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.
The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Loncar Cancer Immunotherapy ETF ranks in the 43th percentile within its peer group and in the 82nd percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.
CNCR MSCI FaCS and Factor Box
MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.
CNCR Summary Data
CNCR Portfolio Data
CNCR Index Data
CNCR Portfolio Management
CNCR Tax Exposures
CNCR Fund Structure
CNCR Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CNCR. CNCR is rated a 3 out of 5.
CNCR Sector/Industry Breakdown
CNCR Top 10 Holdings[View All]
CNCR Economic Development
CNCR Performance Statistics
CNCR MSCI ESG Ratings
CNCR Benchmark Comparison Summary
CNCR Benchmark Comparison Market Cap Size